Humanigen HGEN
$ 0.04
-81.12%
Quarterly report 2023-Q1
added 05-15-2023
Humanigen Balance Sheet 2011-2024 | HGEN
Annual Balance Sheet Humanigen
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-45 M | -67.7 M | 3.14 M | 1.87 M | 18.6 M | 1.38 M | -8.43 M | 5 K | -44.2 M | -1.12 M | -3.34 M | |
Long Term Debt |
- | 25 M | - | 1.25 M | 1.22 M | 1.35 M | 1.27 M | - | - | 6.79 M | 9.83 M | - |
Long Term Debt Current |
- | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | 2.34 M | 1.25 M | 1.22 M | 1.35 M | 1.27 M | 5.41 M | 311 K | 6.79 M | 10.2 M | 400 K |
Total Current Liabilities |
56.2 M | 68.7 M | 20.4 M | 13.6 M | 8.26 M | 24.7 M | 7.82 M | - | 18.1 M | 11.4 M | 7.22 M | - |
Total Liabilities |
58 M | 94.7 M | 22.8 M | 14.8 M | 9.48 M | 26 M | 9.1 M | 5.41 M | 18.4 M | 18.2 M | 17.5 M | 8.51 M |
Deferred Revenue |
883 K | 4.14 M | 1.87 M | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-682 M | -611 M | -374 M | -285 M | -275 M | -263 M | -241 M | -214 M | -178 M | -140 M | -98.3 M | -74.8 M |
Total Assets |
11.2 M | 71.1 M | 68.3 M | 523 K | 1.37 M | 1.67 M | 4.72 M | 11.1 M | 43 M | 78.7 M | 24.5 M | 19.4 M |
Cash and Cash Equivalents |
10.2 M | 70 M | 67.7 M | 143 K | 814 K | 737 K | 2.91 M | 8.43 M | 10.9 M | 54.2 M | 10.9 M | 3.34 M |
Book Value |
-46.8 M | -23.7 M | 45.5 M | -14.3 M | -8.11 M | -24.3 M | -4.38 M | 5.73 M | 24.6 M | 60.5 M | 7.08 M | 10.8 M |
Total Shareholders Equity |
-46.8 M | -23.7 M | 45.5 M | -14.3 M | -8.11 M | -24.3 M | -4.38 M | 5.73 M | 24.6 M | 60.5 M | -94.9 M | -72.3 M |
All numbers in USD currency
Quarterly Balance Sheet Humanigen
2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | - | - | 22.5 M | 25.2 M | 25 M | 24.8 M | 24.6 M | 24.4 M | - | - | - | 7.32 M | 6.49 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | 2.34 M | - | - | - | 1.25 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
54.8 M | 58 M | 78.4 M | 99.5 M | 96.4 M | 94.7 M | 95.6 M | 78 M | 81.8 M | 22.8 M | 22.8 M | 22.8 M | 22.8 M | 14.8 M | 14.8 M | 14.8 M | 14.8 M | 9.48 M | 9.48 M | 9.48 M | 9.48 M | 26 M | 26 M | 26 M | 26 M | 9.1 M | 9.1 M | 9.1 M | 9.1 M | 5.41 M | 5.41 M | 5.41 M | 5.41 M | 18.4 M | 18.4 M | 18.4 M | 18.4 M | 18.2 M | 18.2 M | 18.2 M | 18.2 M | 17.5 M | 17.5 M | 17.5 M | 17.5 M | 8.51 M | 8.51 M | 8.51 M | - |
Deferred Revenue |
883 K | 883 K | 884 K | 3.09 M | 4.13 M | 4.14 M | 4.14 M | 4.14 M | 4.14 M | 1.87 M | 1.87 M | 1.87 M | 1.87 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 5.63 M | 5.63 M | 5.63 M | - |
Retained Earnings |
-686 M | -682 M | -686 M | -663 M | -632 M | -611 M | -578 M | -511 M | -440 M | -374 M | -374 M | -374 M | -374 M | -285 M | -285 M | -285 M | -285 M | -275 M | -275 M | -275 M | -275 M | -263 M | -263 M | -263 M | -263 M | -241 M | -241 M | -241 M | -241 M | -214 M | -214 M | -214 M | -214 M | -178 M | -178 M | -178 M | -178 M | -140 M | -140 M | -140 M | -140 M | -98.3 M | -98.3 M | -98.3 M | -98.3 M | -74.8 M | -74.8 M | -74.8 M | - |
Total Assets |
5.12 M | 11.2 M | 26 M | 49.4 M | 71.3 M | 71.1 M | 77.9 M | 122 M | 98.8 M | 68.3 M | 68.3 M | 68.3 M | 68.3 M | 523 K | 523 K | 523 K | 523 K | 1.37 M | 1.37 M | 1.37 M | 1.37 M | 1.67 M | 1.67 M | 1.67 M | 1.67 M | 4.72 M | 4.72 M | 4.72 M | 4.72 M | 11.1 M | 11.1 M | 11.1 M | 11.1 M | 43 M | 43 M | 43 M | 43 M | 78.7 M | 78.7 M | 78.7 M | 78.7 M | 24.5 M | 24.5 M | 24.5 M | 24.5 M | 19.3 M | 19.3 M | 19.3 M | - |
Cash and Cash Equivalents |
3.1 M | 10.2 M | 24.7 M | 47 M | 68.9 M | 70 M | 76.5 M | 121 M | 92.9 M | 67.7 M | 67.7 M | 67.7 M | 67.7 M | 143 K | 143 K | 143 K | 143 K | 814 K | 814 K | 814 K | 814 K | 737 K | 737 K | 737 K | 737 K | 3.01 M | 2.91 M | 2.91 M | 2.91 M | 8.43 M | 8.43 M | 8.43 M | 8.43 M | 10.9 M | 10.9 M | 10.9 M | 10.9 M | 54.2 M | 54.2 M | 54.2 M | 54.2 M | 10.9 M | 10.9 M | 10.9 M | 10.9 M | 3.34 M | 3.34 M | 3.34 M | - |
Book Value |
-49.7 M | -46.8 M | -52.4 M | -50.1 M | -25 M | -23.7 M | -17.6 M | 43.7 M | 17 M | 45.5 M | 45.5 M | 45.5 M | 45.5 M | -14.3 M | -14.3 M | -14.3 M | -14.3 M | -8.11 M | -8.11 M | -8.11 M | -8.11 M | -24.3 M | -24.3 M | -24.3 M | -24.3 M | -4.38 M | -4.38 M | -4.38 M | -4.38 M | 5.73 M | 5.73 M | 5.73 M | 5.73 M | 24.6 M | 24.6 M | 24.6 M | 24.6 M | 60.5 M | 60.5 M | 60.5 M | 60.5 M | 7.08 M | 7.08 M | 7.08 M | 7.08 M | 10.8 M | 10.8 M | 10.8 M | - |
Total Shareholders Equity |
-49.7 M | -46.8 M | -52.4 M | -50.1 M | -25 M | -23.7 M | -17.6 M | 43.7 M | 17 M | 45.5 M | 45.5 M | 45.5 M | 45.5 M | -14.3 M | -14.3 M | -14.3 M | -14.3 M | -8.11 M | -8.11 M | -8.11 M | -8.11 M | -24.3 M | -24.3 M | -24.3 M | -24.3 M | -4.38 M | -4.38 M | -4.38 M | -4.38 M | 5.73 M | 5.73 M | 5.73 M | 5.73 M | 24.6 M | 24.6 M | 24.6 M | 24.6 M | 60.5 M | 60.5 M | 60.5 M | 60.5 M | -94.9 M | -94.9 M | -94.9 M | -94.9 M | -72.3 M | -72.3 M | -72.3 M | - |
All numbers in USD currency